No, semaglutide is a completely different medication from insulin
The real question for cagrilintide isnt whether it beats tirzepatide solo, but whether its mechanism earns it a complementary role: either as part of a combination like CagriSema or as a standalone option for people who need something outside the GLP-1 family
Conversely, in a Sprague-Dawley rat model of sepsis, cell-wall extracts from Lactobacillus gasseri ATC33323 enhanced the release of inflammatory mediators, including MIP-1, MCP-1, TNF-, and IL-1 (231)
[14] The identity of the receptor or receptors that mediate these E-peptide effects remains, as of the current literature, unresolved and, as the in-vivo work discussed below shows, the claim of full IGF-1R independence is itself contested by studies in which E-peptide-driven hypertrophy did require the receptor